Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Dec;29(12):1567-1575.
doi: 10.1080/09540121.2017.1316356. Epub 2017 May 3.

Receipt and timing of HIV drug resistance testing in six U.S. jurisdictions

Sharoda Dasgupta  1 , H Irene Hall  1 , Angela L Hernandez  1 , M Cheryl Bañez Ocfemia  1 , Neeraja Saduvala  2 , Alexandra M Oster  1
Affiliations

Receipt and timing of HIV drug resistance testing in six U.S. jurisdictions

Sharoda Dasgupta et al. AIDS Care. 2017 Dec.

Abstract

The Department of Health and Human Services recommends drug resistance testing at linkage to HIV care. Because receipt and timing of testing are not well characterized, we examined testing patterns among persons with diagnosed HIV who are linked to care. Using surveillance data in six jurisdictions for persons aged ≥13 years with HIV infection diagnosed in 2013, we assessed the proportion receiving testing, and among these, the proportion receiving testing at linkage. Multivariable log-binomial regression modeling estimated associations between selected characteristics and receipt of testing (1) overall, and (2) at linkage among those tested. Of 9,408 persons linked to care, 66% received resistance testing, among whom 68% received testing at linkage. Less testing was observed among male persons who inject drugs (PWID), compared with men who have sex with men (adjusted prevalence ratio [aPR]: 0.88; 95% confidence interval [CI]: 0.81-0.97) and persons living in areas with population <500,000 compared with those in areas with population ≥2,500,000 (aPR: 0.88; CI: 0.84-0.93). In certain jurisdictions, testing was lower for persons with initial CD4 counts ≥500 cells/mm3, compared with those with CD4 counts <200 cells/mm3 (aPR range: 0.80-0.85). Of those tested, testing at linkage was lower among male PWID (aPR: 0.85; CI: 0.75-0.95) and, in some jurisdictions, persons with CD4 counts ≥500 cells/mm3 (aPR range: 0.63-0.73). Two-thirds of persons with diagnosed HIV who were linked to care received resistance testing, and most received testing at linkage as recommended. Improving receipt and timing of testing among male PWID, persons in less populous settings, and in all jurisdictions, regardless of CD4 count, may improve care outcomes.

Keywords: HIV; linkage; resistance testing.

PubMed Disclaimer

Conflict of interest statement

Disclosure statement

No potential conflict of interest was reported by the authors.

References

    1. Bradley H, Hall HI, Wolitski RJ, Van Handel MM, Stone AE, LaFlam M, Valleroy LA. Vital signs: HIV diagnosis, care, and treatment among persons living with HIV–United States, 2011. Morbidity and Mortality Weekly Report. 2014;63(47):1113–1117. - PMC - PubMed
    1. Buchacz K, Young B, Palella FJ, Jr, Armon C, Brooks JT HIV Outpatient Study (HOPS) investigators. Trends in use of genotypic resistance testing and frequency of major drug resistance among antiretroviral-naive persons in the HIV outpatient study, 1999–2011. Journal of Antimicrobial Chemotherapy. 2015;70(8):2337–2346. doi: 10.1093/jac/dkv120. - DOI - PubMed
    1. Centers for Disease Control and Prevention. Monitoring selected national HIV prevention and care objectives by using HIV surveillance dataUnited States and 6 dependent areas, 2014. HIV Surveillance Supplemental Report 2016. 2015;21(4) http://www.cdc.gov/hiv/library/reports/surveillance.
    1. Centers for Disease Control and Prevention. Diagnoses of HIV infection in the United States and dependent areas, 2014. HIV Surveillance Report, 2014. 2016;26 http://www.cdc.gov/hiv/library/reports/surveillance/
    1. Conrad C, Bradley HM, Broz D, Buddha S, Chapman EL, Galang RR, Duwve JM. Community outbreak of HIV infection linked to injection drug use of Oxymorphone–Indiana, 2015. Morbidity and Mortality Weekly Report. 2015;64(16):443–444. - PMC - PubMed

Substances